Skip to main content
. 2020 Jan 9;10:70. doi: 10.1038/s41598-019-56953-3

Figure 12.

Figure 12

Effects of SM-specific deletion of Cav1.2 on popliteal lymphatic contractile function. (A) Contractile patterns in a PL from a Cav1.2 floxed mouse (without Cre) after tamoxifen administration 12 days prior to the experiment. Contraction patterns are essentially identical to those of PLs from WT mice (See Fig. 6A). (B) Complete absence of large-amplitude, propulsive contractions in a PL from a SM-specific Cav1.2 KO mouse. The vessel exhibits only very small amplitude vasomotion, which is mostly independent of the pressure level. (C) Expanded y-axis scale showing the vasomotion pattern in another PL from a SM-specific Cav1.2 KO mouse. (D–G) Summary of contractile parameters for Cav1.2fl/fl (control) and SMMHC-CreERT2; Cav1.2fl/fl mice studied 10–12 days after tamoxifen administration. With one exception all parameters at all pressures were significantly different between the two groups. The exception was tone at 0.5 cmH2O. Note that tone in SM-specific Cav1.2 KO vessels is ~3-fold higher than in the corresponding Cav1.2 floxed controls at every pressure except 0.5 cmH2O.